The Pharmaceutical & Healthcare Association of the Philippines (PHAP) yesterday said it will work on the introduction of new medicines in the country to improve the health status of Filipinos, citing three lessons learned from policies created and implemented during the pandemic.
“First, regulatory processes can be accelerated without compromising the high standards set by the government. Second, the government can centralize the procurement of medicines and vaccines to secure supply, and make these available for free or at lower prices. And third, the continued open collaboration between the public and private sector can save more lives and eventually kickstart economic recovery,” said
Dr. Diana Edralin, PHAP new president,
In a statement, Edralin also explained the landmark Universal Healthcare (UHC) Act and the National Integrated Cancer Control Act (NICCA) also have provisions that could expedite the entry of new medicines and vaccines in the country to ensure that no Filipino is left behind in the race for quality healthcare.
Edralin committed to advance innovation and strengthen collaborations with the government as the country recovers from the pandemic, and as it prepares for future health threats.
“We have witnessed that the health of the nation is crucial to its social and economic progress. Due to its wider implications, health should be prioritized. Public and private investments and collaborations to strengthen the healthcare system will be crucial as we navigate our way out of the pandemic, and prepare for any future health concerns. As a science-driven organization, we are in unique position to partner with the government and the nation to ensure that innovative and life-saving medicines and vaccines are available to Filipino patients at the time they are needed,” said Edralin.
Since the pandemic, PHAP has been working with the government in its COVID-19 response through the research and development of safe and effective medicines and vaccines; the continued supply of medicines and vaccines despite major challenges; the cascade of verified health information; and the support for healthcare workers and communities through the PHAPCares Foundation. Irma Isip
